ClinicalTrials.Veeva

Menu

Italian Lung Cancer Observational Study (LUCENT)

T

The Mediterranean Institute for Transplantation and Advanced Specialized Therapies

Status

Invitation-only

Conditions

Lung Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT05851755
IRRB/04/23

Details and patient eligibility

About

LUCENT is an observational study focused on malignant pulmonary and tracheo-bronchial disease. It involves a large proportion of reference Italian thoracic surgery centers. The relevance of the study is related to the epidemiology of lung cancer in the world - also known as "Big Killer" - and the high mortality rates both in males and females.

The aim of his prospective study is to collect a large bulk of postoperative patients' outcome data and to produce up-to-date descriptive statistics of patients undergoing surgery for lung cancer. These results will be pivotal to compare the clinical results of all the relevant specialities involved in the care of lung cancer such as medical oncologists and radiation oncologists.

Enrollment

1,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with lung cancer
  • informed consent

Exclusion criteria

  • alcohol or drug abuse
  • age < 18
  • inability to express consent

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems